Skip to main content
. 2020 Dec 14;2020:6782659. doi: 10.1155/2020/6782659

Figure 1.

Figure 1

(a) Expression of mRNA for IGF-1 in CVeD (chronic venous disease) and HV (healthy controls) in arbitrary units. (b–d) Images showing immunostaining for IGF-1 in CVD patients in the three venous wall robes (asterisk) and CV. I: intimate robe; M: middle robe; A: adventitious robe.